| # | Drug | Count |
|---|---|---|
| 0 | LAMOTIRIGINE | 11 |
| 1 | LAMOTRIGINE | 11 |
| 2 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 11 |
| 3 | LAMOTRIGINE EXTENDED-RELEASE | 11 |
| 4 | METHOTREXATE SODIUM | 8 |
| 5 | METHOTREXATE | 7 |
| 6 | ESLICARBAZEPINE ACETATE | 6 |
| 7 | PAROXETINE HYDROCHLORIDE | 5 |
| 8 | TACROLIMUS | 5 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESLICARBAZEPINE ACETATE | 6 | 0.0018 |
| 1 | NIRSEVIMAB | 3 | 0.0017 |
| 2 | TAZAROTENE | 1 | 0.0008 |
| 3 | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | 1 | 0.0006 |
| 4 | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | 1 | 0.0006 |
| 5 | PROPYLTHIOURACIL | 1 | 0.0005 |
| 6 | ONASEMNOGENE ABEPARVOVEC-XIOI | 1 | 0.0004 |
| 7 | CHORIOGONADOTROPIN ALFA | 1 | 0.0004 |
| 8 | NEOMYCIN SULFATE | 1 | 0.0004 |
| 9 | ASFOTASE ALFA | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 3 | 0.0017 |
| 1 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0003 |
| 2 | Vitamin K [EPC] | 2 | 0.0002 |
| 3 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 5 | Protease Inhibitor [EPC] | 5 | 0.0001 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 5 | 0.0001 |
| 9 | Anti-epileptic Agent [EPC] | 14 | 0.0001 |